Approval · Notice of Compliance 34429 · 2024
ANTIROBE: Notice of Compliance 34429
Issued November 22, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34429
- Date
- November 22, 2024
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal from the package insert of information pertaining to Antirobe Aquadrops Solution, following discontinuation of marketing of this specific dosage form
Products in this notice
Medicinal ingredients
- CLINDAMYCIN HCL 25 MG per CAP
- CLINDAMYCIN HCL 75 MG per CAP
- CLINDAMYCIN HCL 150 MG per CAP